These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 2179402
21. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer. Pession A, Prete A, Paolucci G. Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370 [Abstract] [Full Text] [Related]
22. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients. Kinsey SE, Machin SJ, Goldstone AH. J Hosp Infect; 1990 Apr; 15 Suppl A():49-53. PubMed ID: 1971645 [Abstract] [Full Text] [Related]
23. [Infection in patients with granulocytopenia. Therapeutic results of 3 different antimicrobial programs in 162 febrile episodes]. Avilés Miranda A, Conte Lanza G, Sinco Angeles A, Ambriz Fernández R, Pizzuto J. Sangre (Barc); 1982 Apr; 27(3):324-32. PubMed ID: 7157128 [No Abstract] [Full Text] [Related]
24. Monotherapy versus combination therapy for febrile neutropenia. Ramphal R. Int J Hematol; 1998 Oct; 68 Suppl 1():S21-5. PubMed ID: 9838740 [No Abstract] [Full Text] [Related]
25. Response rates to a staged antibiotic regimen in febrile neutropenic patients. Barnes RA, Rogers TR. J Antimicrob Chemother; 1988 Nov; 22(5):759-63. PubMed ID: 3209532 [Abstract] [Full Text] [Related]
27. Empirical antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Klastersky J. Recent Results Cancer Res; 1988 Nov; 108():53-60. PubMed ID: 3051212 [No Abstract] [Full Text] [Related]
28. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Walsh TJ, Lee J, Lecciones J, Rubin M, Butler K, Francis P, Weinberger M, Roilides E, Marshall D, Gress J. Rev Infect Dis; 1991 Nov; 13(3):496-503. PubMed ID: 1866556 [Abstract] [Full Text] [Related]
29. [Antibiotherapy in the patient with granulocytopenic cancer]. Van Der Auwera P, Meunier F. Pathol Biol (Paris); 1990 Apr; 38(4):302-6. PubMed ID: 2198526 [Abstract] [Full Text] [Related]
33. Controversies in the management of febrile neutropenic cancer patients. Rubin M, Hathorn JW, Pizzo PA. Cancer Invest; 1988 Apr; 6(2):167-84. PubMed ID: 3132310 [No Abstract] [Full Text] [Related]
34. Fever, neutropenia and malignancy: a clinical syndrome in evolution. Pennington JE. Cancer; 1977 Mar; 39(3):1345-9. PubMed ID: 912664 [Abstract] [Full Text] [Related]
35. Review of amikacin usage in the EORTC trials. Zinner SH. Am J Med; 1985 Jul 15; 79(1A):17-20. PubMed ID: 3895903 [Abstract] [Full Text] [Related]
36. Role of antimicrobial combinations in the therapy of infections in neutropenic patients. Gialdroni Grassi G, Grassi C. Chemioterapia; 1987 Jun 15; 6(2 Suppl):398-400. PubMed ID: 3334582 [No Abstract] [Full Text] [Related]
37. Empiric antibacterial therapy in granulocytopenia induced by cancer chemotherapy. Rubin RH. Ann Intern Med; 1988 Jan 15; 108(1):134-6. PubMed ID: 3337488 [No Abstract] [Full Text] [Related]
39. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease. Tattersall MH, Hutchinson RM, Gaya H, Spiers AS. Eur J Cancer (1965); 1973 Jun 15; 9(6):417-23. PubMed ID: 4372049 [No Abstract] [Full Text] [Related]
40. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients. Croydon E, Weerts D. Chemioterapia; 1987 Jun 15; 6(2 Suppl):405-7. PubMed ID: 3334585 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]